SVF Endurance (Cayman) Ltd, 10% Owner at Vir Biotechnology, Inc. (VIR), sold 49,006 shares at $6.50 ($319K) on 2025-10-28, disclosed to the SEC on 2025-10-30.
Scheduled sale ($319k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.50 | 24,453 | $159K | 49.9% |
| 2 | $6.50 | 24,453 | $159K | 49.9% |
| 3 | $6.49 | 100 | $649 | 0.2% |
| Total | $6.50 avg | 49,006 | $319K | 100% |
| Filing → |
| VIR | SELL | 2025-10-22 | $2.7M | — | Filing → |
| VIR | SELL | 2025-10-17 | $359K | — | Filing → |
| VIR | SELL | 2025-10-07 | $5.8M | — | Filing → |